Osteoporosis in patients with prostate cancer on long-term androgen deprivation therapy: an increasing but under-recognised problem

BJU Int. 2010 Sep;106(5):726-7; author reply 727. doi: 10.1111/j.1464-410X.2010.09605_1.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Androgen Antagonists / adverse effects*
  • Gonadotropin-Releasing Hormone / agonists*
  • Humans
  • Male
  • Osteoporosis / chemically induced
  • Osteoporosis / prevention & control*
  • Prostatic Neoplasms / drug therapy*

Substances

  • Androgen Antagonists
  • Gonadotropin-Releasing Hormone